SEC Form 4 · accession 0000899243-17-023313
Calithera Biosciences, Inc. · CALA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sumita Ray
Officer — See Remarks
Period of report
Sep 29, 2017
Accepted (ET)
Oct 3, 2017 · 5:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $15.75 | Sep 29, 2017 | A | 75,000 | A | — | Sep 29, 2027 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1One-fourth (1/4th) of the Option vests one year after May 23, 2017; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter. The Option shall be subject to accelerated vesting as set forth in the Company's Severance Benefit Plan.
Remarks
SVP, GENERAL COUNSEL & CHIEF COMPLIANCE OFFICER